Econ Financial Services’s Gilead Sciences GILD Stock Holding History

Econ Financial Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-26,159	Closed	-$2.19M	–	90
2024 Q3	$2.19M	Buy	26,159 +7,929	+43%	+$605K	1.23%	16
2024 Q2	$1.25M	Buy	18,230 +3,856	+27%	+$257K	0.78%	41
2024 Q1	$1.05M	Buy	+14,374	New	+$1.11M	0.65%	56
2022 Q4	–	Sell	-54,921	Closed	-$3.39M	–	63
2022 Q3	$3.39M	Buy	54,921 +9,601	+21%	+$605K	2.79%	7
2022 Q2	$2.8M	Sell	45,320 -75	-0.2%	-$4.64K	2.26%	12
2022 Q1	$2.7M	Buy	45,395 +18,719	+70%	+$1.2M	2%	20
2021 Q4	$1.94M	Buy	+26,676	New	+$1.84M	1.43%	21
2019 Q2	$396K	Buy	5,866 +1,398	+31%	+$92K	0.55%	36
2019 Q1	$290K	Buy	4,468 +587	+15%	+$39K	0.43%	39
2018 Q4	$243K	Buy	+3,881	New	+$271K	0.37%	58

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Econ Financial Services's GILD Position: Q4 2024 in Review

Econ Financial Services sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 26,159 shares — an estimated $2.19M sold.

Econ Financial Services first reported a position in GILD in Q4 2018 and held it in 10 quarters. The position peaked at $3.39M in Q3 2022. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

Econ Financial Services reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
Econ Financial Services sold 26,159 Gilead Sciences shares in Q4 2024, an estimated $2.19M.
Econ Financial Services first reported a position in Gilead Sciences in Q4 2018 and held it in 10 quarters.
Econ Financial Services's Gilead Sciences position peaked at $3.39M in Q3 2022.
1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Econ Financial Services's 13F filing for Q4 2024, filed 27 Jan 2025.